Increased PD-L1 expression in erlotinib-resistant NSCLC cells with <i>MET</i> gene amplification is reversed upon MET-TKI treatment
Christina Demuth(Aarhus University Hospital), Boe Sandahl Sørensen(Aarhus University Hospital)
Cited by 35
Related Papers
Exosomal Proteins as Diagnostic Biomarkers in Lung Cancer
|Journal of Thoracic Oncology|2016|308
Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer—evaluation in a nationwide Danish cohort
|Annals of Oncology|2023|71
Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal Cancer
|Cancers|2023|12
DREAMS: deep read-level error model for sequencing data applied to low-frequency variant calling and circulating tumor DNA detection
|Genome biology|2023|12
Circulating tumour DNA and risk of recurrence in patients with asymptomatic versus symptomatic colorectal cancer
|British Journal of Cancer|2024|10